Significance of heparin induced thrombocytopenia (HIT) in COVID-19: a systematic review and meta-analysis
Description
Heparin-induced thrombocytopenia (HIT) occurs in approximately 3% of patients receiving heparinoids. About 30-75% of patients with type 2 of HIT develop thrombosis as a result of platelet activation. The most important clinical symptom is
